Exciting news! We're making it easier for you to stay up-to-date on all things #Alimentiv. This means our dedicated Alimentiv Statistics account is closing next week, but don't worry – all of our valuable insights and posts will now be found here, on our main Alimentiv page. Be sure to follow to keep getting the information you need and stay ahead of the curve. #Statistics #DataDriven #Gastroenterology #CRO #DrugDevelopment #PrecisionMedicine #MedicalResearch #ClinicalTrials
About us
From 1986 to 2020 we operated as Robarts Clinical Trials and built a strong foundation in the medical research community. In 2020, we became Alimentiv but retained our commitment to clinical trials, medical imaging, and precision medicine for GI-related ailments.
- Website
-
https://alimentiv.com/
External link for Alimentiv
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- London, Ontario
- Type
- Privately Held
- Founded
- 1986
- Specialties
- Clinical Trials Design, Planning, Safety Management, Custom Services, and Study Management
Locations
-
Primary
100 Dundas St
Suite 200
London, Ontario N6A 5B6, CA
-
4350 Executive Dr
San Diego, US
-
Pietersbergweg 17
Amsterdam, NL
Employees at Alimentiv
Updates
-
🇦🇺 Alimentiv is in Australia! The Alimentiv Site Network (ASN) is now firmly established Down Under, with most international studies including Australian centers. With Australia joining our 5,000+ GI research sites in over 60 countries, we’re further expanding our full-service clinical trial support for diverse GI indications. Discover the details in our exclusive interview with Peter Westerveld: https://bit.ly/3WbQDQ3 #Alimentiv #Australia #SiteNetwork #Gastroenterology #PrecisionMedicine #MedicalResearch #ClinicalTrials
-
✨We are thrilled to share we had our first day at our new co-working space in Toronto last week! We've set up our space just as we like it, and we even had a morning coffee session on the patio. Looking forward to welcoming our fellow Alimentarians here soon! ☕ #TorontoOffice #NewBeginnings #Alimentiv
-
🎉 We have reached 20,000 followers on LinkedIn This is a huge milestone for Alimentiv, and we want to thank all our followers for the continued support and engagement! 🎉. We look forward to continuing this journey with clients, colleagues and collaborators as we reach new heights together. 🚀 Stay tuned for more exciting news and insights, coming your way. ✨ Onto our next milestone! 🙌 #Alimentiv #TeamAlimentiv #Followers #ThankYou
-
Happy 4th of July to all of our sponsors, partners, and our American colleagues! Wishing everyone a safe and joyful holiday celebration! 🎆 #IndependenceDay #July4th #Alimentiv
-
🇨🇦 Since 1867, Canadians all over the country and around the world celebrate Canada Day on July 1st, honouring our culture, achievements, and history. At Alimentiv we're proud to be a Canadian organization and wish everyone celebrating a very happy Canada Day! 🍁🫎 🎉#CanadaDay #CanadianPride #Alimentiv
-
#DYK we have a scientific publications section on our website 📰 ? Interested in finding out about our latest medical research📊? This is the place to find it ⭐ 🔗https://lnkd.in/g7nxM_S3 #Alimentiv #MedicalResearch #IBD #Publications
-
AOCC 2024 recap! Exciting to see the global effort in tackling rising IBD rates in Asia. Alimentiv is looking forward to impactful collaborations and helping move forward research in #IBD. #SiteNetwork #ClinicalResearch 👇
AOCC 2024 - Alimentiv’s Site Network was there and what a great experience it was! After three highly productive and informative days at the excellent AOCC 2024 congress, time for a video to capture my experience. Please let me know your feedback. With IBD rates increasing accross Asia, it is great to see the collaborative spirit amongst IBD researchers across the region and across the world to address this serious concern. Having met so many key investigators at the conference and seeing the interest from them in Alimentiv and establishing (further) collaborations is very rewarding and I am sure we can do great work together. Let’s fight this wave of IBD coming to Asia together!
-
Alimentiv is proud to collaborate with Mage Biologics on this project! Congratulations on dosing the first subject in a Phase 1 trial with MB-001, an orally administered antibody for IBD! Tillotts Pharma AG👏
We are very proud of having moved MB-001 into clinical testing so fast. A great thank you goes to Tillotts Pharma AG and Alimentiv for having provided excellent support as well as to TVM Capital Healthcare and to Chorus for their valuable advice.
-
The Asian Organization for Crohn’s & Colitis conference is just around the corner! If you’re attending the event in Xi’an, China, on June 14, be sure to connect with Peter Westerveld to learn more about Alimentiv! #Alimentiv #SiteNetwork #ClinicalTrials #ClinicalResearch #IBD
China here we come! Ready to fly out to China for my attendance to the AOCC congress in Xi’An from June 14-16. I will be meeting with many key investigators from the APAC region and other countries to discuss current and future collaborations. Looking forward to seeing many familiar and new faces and further engage GI investigators for the Alimentiv Site Network!